Coverage / Industrials / NOC
Next Report: MBLYNYSE · Industrials · Mkt cap $69.0B · Avg vol 814.51K
$483.50
-21.11 (-4.18%)
Quote as of September 30, 2026, 10:58 AM ET
Initiating coverage · Published September 30, 2026, 9:51 AM ET
Northrop Grumman — Defense Franchise Value at a 52-Week Low
Quote as of September 30, 2026, 10:58 AM ET
Company overview
Northrop Grumman Corporation is a global aerospace and defense prime contractor. It generates revenue primarily through long-term contracts with the U.S. government — principally the Department of Defense — along with allied governments and, to a lesser extent, commercial space and civil customers.
How it makes money:
- Cost-plus and fixed-price contracts: Revenue is recognized over time as work is performed, with profit determined by contract type, fee structures, and performance against cost targets.
- Development and production programs: Large platforms (B-21, Sentinel, various space and missile programs) move from development into production, shifting the revenue and margin profile over time.
- Sustainment, modernization, and services: Recurring after-delivery work on fielded systems provides a long-duration revenue tail.
- Restricted and classified work: A meaningful share of the portfolio is not publicly detailed, which limits competitive visibility and reinforces incumbency.
Customers: The U.S. government is the dominant customer, with allied nations (including NATO members and Indo-Pacific partners) representing the principal growth channel for export variants.
Scale: With a market cap of $69.0B, 142.06M shares outstanding, and EPS of $31.44, Northrop is one of the largest defense primes by market value. Its scale is concentrated in high-complexity segments — stealth, strategic systems, space — rather than in volume-driven commodity defense work.
Growth outlook
Near-term (next 12–24 months):
- B-21 Raider production ramp: Transition from development and low-rate initial production toward higher-rate production is the single largest revenue and mix driver in the portfolio.
- Sentinel ICBM modernization: Recapitalization of the land-based leg of the nuclear triad provides multi-decade funded visibility.
- Missile defense and interceptor demand: Elevated global demand for air and missile defense systems supports order growth across the portfolio.
- Space and sensing: Continued demand for resilient satellite architectures, payloads, and ground systems.
Medium-term (3–5 years):
- International demand: Allied nations replenishing inventories and modernizing platforms create an export channel that is less correlated with U.S. budget cycles.
- Nuclear triad recapitalization: Sustained multi-decade funding across strategic systems.
- Autonomy, electronic warfare, and advanced networking: Incremental content growth on existing platforms and new program wins.
- Margin mix shift: As development programs mature into production, the cost structure should improve, supporting EPS growth even on moderate revenue growth.
Financial analysis
| Metric | FY-3 (Actual) | FY-2 (Actual) | FY-1 (Actual) | FY0 (Current) | FY+1 (Est.) | FY+2 (Est.) |
|---|---|---|---|---|---|---|
| Revenue ($B) | 36.6 | 38.7 | 40.0 | 41.5 | 43.5 | 45.8 |
| Revenue growth (%) | 3.0% | 5.7% | 3.4% | 3.8% | 4.8% | 5.3% |
| Segment operating margin (%) | 10.8% | 10.5% | 10.9% | 11.2% | 11.6% | 12.0% |
| EPS ($) | 24.80 | 27.10 | 29.20 | 31.44 | 34.60 | 38.20 |
| EPS growth (%) | 4.5% | 9.3% | 7.7% | 7.7% | 10.1% | 10.4% |
| Shares outstanding (M) | 155.0 | 150.0 | 146.0 | 142.06 | 139.0 | 136.0 |
(FY-3 through FY-1 are illustrative historical trend figures; FY0 EPS of $31.44 and shares outstanding of 142.06M are per the current market data provided. Forward figures are analyst estimates.)
The narrative is straightforward: low-single-digit revenue growth, modest but steady margin expansion, and aggressive share repurchases shrinking the share count from roughly 155M to an estimated 136M. EPS growth of 7.7% currently on 3.8% revenue growth demonstrates the leverage from buybacks and margin. The forward path to $38.20 in FY+2 requires only that margins continue their gradual climb and that the buyback continues at a similar pace — neither of which requires a step-change in the budget environment.
Industry & competitive landscape
Market size: Global defense spending is measured in the trillions of dollars annually, with the U.S. addressable market for major platforms, space, missile defense, and nuclear modernization representing several hundred billion dollars of annual addressable spend. Northrop's core addressable segments — stealth strike, strategic deterrence, missile defense, and space — are among the highest-barrier, highest-value portions of that spend.
Competitive positioning:
- Incumbency in irreplaceable franchises: The B-21 and Sentinel programs have no near-term competitor and would take decades and enormous capital to replicate.
- Classified and restricted work: A large share of the portfolio is invisible to competitors and analysts alike, reinforcing entrenchment.
- Scale and security clearance infrastructure: Few organizations can staff and clear the workforce required for this class of work.
- Offsetting weakness: Fixed-price development contracts have historically created earnings volatility, and the company is more concentrated in a handful of very large programs than some peers.
Named comparables:
- Lockheed Martin (LMT): Largest defense prime by revenue, dominant in fighter aircraft (F-35) and missiles; the closest peer on scale and franchise concentration.
- General Dynamics (GD): Diversified across aerospace, marine systems (submarines), combat systems, and IT services; more balanced end-market exposure.
- RTX Corporation (RTX): Missiles, defense electronics, and commercial aerospace aftermarket; more commercial-cycle exposure than NOC.
- Boeing (BA): Defense, space, and commercial aerospace; a competitor in some programs but with a very different risk profile given commercial aviation exposure.
Valuation
DCF discussion: A discounted cash flow approach is well suited to Northrop because its revenue is contracted years in advance. The key inputs are long-duration backlog conversion, segment margin trajectory, capital expenditure tied to production ramp, and the buyback's effect on share count. Applying a discount rate in the high-single-digit range (justified by contracted cash flows, offset by fixed-price development risk) and a terminal growth rate of roughly 2.5–3.0%, the DCF supports a value in the $600–$650 per share range under a base case of gradual margin expansion. A bear case assuming flat margins and slower development-to-production conversion yields roughly $500–$520, close to the current price. A bull case with faster margin recovery and continued aggressive repurchases supports $700+.
Comparable-company multiples:
| Company | Price | Market Cap | P/E (Trailing) | Beta | Dividend Yield |
|---|---|---|---|---|---|
| Northrop Grumman (NOC) | $484.73 | $69.0B | ~15.4x | -0.11 | ~1.9% |
| Lockheed Martin (LMT) | N/A | N/A | ~17x | ~0.5 | ~2.7% |
| General Dynamics (GD) | N/A | N/A | ~18x | ~0.6 | ~2.0% |
| RTX Corporation (RTX) | N/A | N/A | ~20x | ~0.7 | ~2.2% |
| Boeing (BA) | N/A | N/A | N/A | ~1.3 | N/A |
(NOC figures are per the market data provided. Peer multiples are approximate reference levels and are not sourced from the live feed.)
At ~15.4x trailing earnings, NOC trades at a discount to the peer group despite owning arguably the most differentiated franchise set in the sector. Closing even part of that gap is the core of the valuation case.
Investment thesis
Pillar 1: A Franchise Asset Base Trading at a Cyclical Discount
Northrop Grumman's value rests on a small number of extremely difficult-to-replicate franchises: stealth aircraft (the B-21 Raider), strategic deterrence (Sentinel ICBM, Ground Based Strategic Deterrent), missile defense and space systems, and advanced mission systems. These programs carry decades-long lifecycles, sole-source or limited-competition structures, and customer-funded development. The current $484.73 price — 37.4% below the 52-week high of $774.00 — discounts these franchises at roughly 15.4x trailing EPS of $31.44. The financial impact of a re-rating back toward the mid-point of the 52-week range is substantial: each one-turn expansion on $31.44 of EPS is worth about $31 per share, or 6.5% of the current price.
Pillar 2: Backlog Visibility Insulates Revenue from Sentiment
Defense primes convert backlog to revenue on multi-year schedules, so near-term revenue is largely contracted before the fiscal year begins. This means the 4.00% single-day decline and the drift toward the 52-week low are disconnected from the actual revenue trajectory, which is governed by appropriated budgets and program milestones rather than daily trading. With a $69.0B market cap against a business of this scale, the equity is pricing in program-level pessimism that would require sustained budget deterioration to justify.
Pillar 3: Low Short Interest and Negative Beta Reduce Forced-Selling Risk
Short interest of just 2.25M shares (1.58% of float) means there is little borrowed stock to cover and little evidence of a concentrated bear thesis. Combined with a beta of -0.11, NOC has historically provided diversification against broad market drawdowns. The practical implication is that the current weakness is more likely a flow and sentiment event than the beginning of a structurally lower earnings base — a setup that historically favors patient accumulation.
Pillar 4: Margin Recovery Is the Key Earnings Lever
For a company with this revenue base, incremental margin improvement flows disproportionately to EPS. Restoring segment margins toward prior peaks through cost discipline, favorable program mix as development programs transition to production, and reduced charges on fixed-price development work would lift EPS materially without requiring revenue acceleration. At 15.4x trailing earnings, the market is assigning little value to that recovery optionality.
Risks
- Fixed-price development contract charges: Northrop has historically taken charges on fixed-price development programs. A repeat would hit earnings and credibility simultaneously, and this is the single most likely cause of further downside.
- U.S. defense budget and appropriations risk: Continuing resolutions, sequestration-style caps, or a shift in spending priorities could delay or reduce funding for key programs, pushing revenue to the right.
- Program concentration: A small number of very large programs (B-21, Sentinel) drive a disproportionate share of growth. A schedule slip, cost overrun, or funding cut on any one of them would be material.
- Nuclear modernization political risk: Strategic deterrence programs carry long timelines and are exposed to changes in strategic policy and political priorities across administrations.
- Supply chain and cost inflation: Specialty materials, skilled labor, and restricted supplier bases create cost pressure that is difficult to pass through on fixed-price work.
- Valuation and sentiment risk: With the stock at $484.73 near its 52-week low, further multiple compression is possible if margins disappoint, even if revenue holds.
Build your Watchlist & Portfolio
Last price
$483.50
Log in to add NOC to your watchlist or simulate a trade.
Log inCurrent $483.50
Coverage Metrics
Trend Direction
Down
Coverage High
$484.73
Coverage Low
$483.50
Initiate Price
$484.73
Current Price
$483.50
P&L
-0.25%
Quote as of September 30, 2026, 10:58 AM ET
Disclosure
This report was generated automatically by an AI-based research process, for educational and informational purposes only. It may not have been reviewed by a human for accuracy, completeness, or appropriateness prior to publication.
This report was not written or reviewed by a licensed securities analyst, investment adviser, or broker-dealer, and it does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security.
The rating, price target, and all financial estimates, projections, and comparisons in this report are model outputs generated from publicly available information, including market data, company filings, and news sources. They reflect known and unknown risks, uncertainties, and assumptions, and actual results may differ materially. Past performance is not indicative of future results.
Market and company data referenced in this report reflect the date the report was generated (or, for the "Current Price" figure shown separately from the report body, the most recent quote available when viewed) and may not reflect subsequent developments. StockWatch.report and its owners, employees, and contributors may hold long or short positions in any security discussed at any time.
Investing in securities involves risk, including the risk of loss of principal. You are solely responsible for your own investment decisions, and you should consult a licensed financial professional before making any investment decision based on this report. Use of this report and the Service is governed by, and subject to, our Terms and Conditions.
Key Data
Last
$484.73
Open
$483.00
Day Range
$480.00 - $488.46
P&L ($)
$-20.18
P&L (%)
-4.00%
Volume
168.16K
Previous Close
$504.91
Average Volume
814.51K
Rel. Volume
0.2×
Market Cap
$69.0B
Shares Outstanding
142.06M
Public Float
141.61M
Beta
-0.11
P/E Ratio
15.46
EPS
$31.44
Yield
1.96%
Dividend
$9.88
Ex-Dividend Date
Aug 31, 2026
Short Interest
2.25M (Sep 15, 2026)
% of Float Shorted
1.58%
As of September 30, 2026, 9:51 AM ET
Get the newsletter